Displaying drugs 2201 - 2225 of 2809 in total
BMS-986094
INX-08189 has been used in trials studying the treatment of Hepatitis C, HCV (Genotype 1), and Hepatitis C Virus.
Investigational
Etoxeridine
Experimental
Illicit
(S)-blebbistatin
Experimental
6-hydroxy-D-norleucine
Experimental
5-Iodo-2'-Deoxyuridine-5'-Monophosphate
Experimental
N-acetyl-D-glucosamine-6-phosphate
Experimental
Cositecan
Cositecan is the novel camptothecin derivative which is also known as Karenitecin. It has been developed for superior oral bioavailability and increased lactone stability. It is used to treat cancer.
Investigational
Edivoxetine
Edivoxetine is a drug which acts as a selective norepinephrine reuptake inhibitor and is currently under development by Eli Lilly for attention-deficit hyperactivity disorder (ADHD) and as an antidepressant treatment. Edivoxetine failed to be approved for major depressive disorder after phase III clinical trials in 2012.
Investigational
Matched Categories: … Alcohols …
Belotecan
Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.
Investigational
IPI-493
IPI-493 has been used in trials studying the treatment of Advanced Malignancies.
Investigational
Delpazolid
Delpazolid (LCB01-0371) is under investigation in clinical trial NCT01554995 (A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study).
Investigational
Metrizamide
Metrizamide is a solute for density gradient centrifugation offering higher maximum solution density without the problems of increased viscosity. It is also used as a resorbable, non-ionic contrast medium.
Experimental
EM-1745
Experimental
O-(N-acetyl-alpha-D-galactosaminyl)-L-serine
Experimental
O2-Sulfo-Glucuronic Acid
Experimental
Displaying drugs 2201 - 2225 of 2809 in total